Trastuzumab Deruxtecan 100 mg: Revolutionizing HER2-Positive Cancer Treatment in

Trastuzumab Deruxtecan (T-DXd) 100 mg, available through Impomed Healthcare in India, represents a breakthrough in the treatment of HER2-positive cancers. This innovative antibody-drug Trastuzumab Deruxtecan 100 mg in India conjugate offers precise targeting of cancer cells while minimizing damage t

0 views • 10 slides